Tag Archives: identify

Type 2 diabetes: The palm test that could identify high blood sugar complications

According to the global diabetes community, stiffness begins in the little finger and spreads to the thumb when you have diabetic cheiroarthropathy. Limited finger movement is paired with waxy, thickened skin on the hands. Over time, if you bring your palms together, the fingers may not be able to touch if you have this condition. If there is a gap between your fingers and palms in this position, you’re advised to see your doctor.

Symptoms of this diabetes complication are often worse at night and include:

  • Numbness or reduced ability to feel pain or temperature changes
  • Tingling or burning sensation
  • Sharp pains or cramps
  • Increased sensitivity to touch — for some people, even a bedsheet’s weight can be painful
  • Serious foot problems, such as ulcers, infections, and bone and joint pain.

If the autonomic nervous system starts to fail due to nerve damage, it can cause bladder or bowel issues.

You may feel nauseous, lose your appetite, and vomit as the digestive system is affected.

Proximal neuropathy can then lead to severe stomach pain, hip, thigh or buttock pain.

High blood pressure: Condiments to avoid [ADVICE]
High cholesterol: Sign in your fingers [INSIGHT]
Diabetes type 2: High blood sugar signs in your feet [TIPS]

It can also cause difficulty for people trying to rise up from a sitting position.

Mononeuropathy can lead to an achy feeling behind one eye, difficulty focusing, double vision, or numbness or tingling in the hands or fingers, except for the pinkie.

The NHS warned that uncontrolled and persistent high blood sugar levels can lead to numerous health issues.

For instance, the condition could lead to heart disease and stroke, blindness, and sexual impotency.

People with diabetes are encouraged to go for regular health check-ups.

A diabetes nurse of doctor should be checking your blood sugar levels every six months.

Then, once a year, you need to be checked over for any loss of feeling in your feet, signs of ulcers or infections.

“Speak to your GP immediately if you have cuts, bruises or numbness in your feet,” instructed the NHS.

Your doctor should also check your blood pressure and cholesterol levels.

It’s also important to get your vision checked every year too; this is so any health complications can be picked up on in the early stages.

Keeping on top of your health is one way to help prevent complications from developing or worsening.

For more support and information on managing type 2 diabetes, please visit the charity Diabetes UK.

Read more
This post originally posted here Daily Express :: Health
Read More

Bitcoin warning as experts identify ‘significant limitation’ to cryptocurrency rebound

The leading digital coin has endured a rough couple of months since it struck an all-time high in April of more than $ 63,000 (£45,320). Today it is trading at $ 32,575 (£23,560), which is down almost two percent from yesterday. The ongoing Bitcoin downside “correction” is similar to previous price activity, which has led some to tip the coin to soon rebound.

But a leaked report by Wall Street giant JPMorgan has warned that El Salvador’s controversial plan to adopt Bitcoin as legal currency could sidetrack those efforts.

They point to the token’s low trading volume outside of major exchanges and its extreme price volatility as possibly “a significant limitation on its potential as a medium of exchange”.

They added: “Daily payment activity in El Salvador would represent [around] four percent of recent on-chain transaction volume and more than one percent of the total value of tokens which have been transferred between wallets in the past year.

“A significant and rising fraction [of Bitcoin is] held by wallets with light turnover.”

The report pointed to Bitcoin trading volumes that commonly exceed $ 50billion per day but mostly happen on major crypto exchanges.

El Salvador president Nayib Bukele believes the adoption of Bitcoin as legal tender in September will boost financial inclusion among the country’s unbanked.

But JPMorgan researchers believe Bitcoin’s “high volatility” will be a major challenge alongside the country’s official dollarisation.

An estimated 2.3 million UK adults now hold cryptocurrency such as Bitcoin – despite warnings of the risks involved – according to the City watchdog.

READ MORE: Dogecoin rebound predicted after Musk’s tweet as analyst tips crypto to surge past $ 1

The figure from the Financial Conduct Authority (FCA) represents a rise of 400,000 since last year and shows an enthusiasm for the assets.

It comes as after the Metropolitan Police seized a record £180million of cryptocurrency in London.

The Met’s economic crime command made the bust after following up intelligence received about the transfer of criminal assets. The investigation is continuing.

The FCA has previously warned investors of the risks that come with investing in cryptocurrency.

They said: “If consumers invest, they should be prepared to lose all their money

“Some investments advertising high returns from crypto assets may not be subject to regulation beyond anti-money laundering.

“Significant price volatility, combined with the difficulties valuing [Bitcoin] reliably, place consumers at a high risk of losses.” 

Express.co.uk does not give financial advice. The journalists who worked on this article do not own Bitcoin.

Read more
This post originally posted here Daily Express :: Finance Feed

Case Reports Identify Guillain-Barré Variants After COVID Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Guillain-Barré syndrome, a rare peripheral nerve disorder that can occur after certain types of viral and bacterial infections, has not to date been definitively linked to infection by SARS-CoV-2 or with vaccination against the virus, despite surveillance searching for such associations.

Spikes in Guillain-Barré syndrome incidence have previously, but rarely, been associated with outbreaks of other viral diseases, including Zika, but not with vaccination, except for a 1976-1977 swine influenza vaccine campaign in the United States that was seen associated with a slight elevation in risk, and was halted when that risk became known. Since then, all sorts of vaccines in the European Union and United States have come with warnings about Guillain-Barré syndrome in their package inserts — a fact that some Guillain-Barré syndrome experts lament as perpetuating the notion that vaccines cause Guillain-Barré syndrome.

Epidemiologic studies in the United Kingdom and Singapore did not detect increases in Guillain-Barré syndrome incidence during the COVID-19 pandemic. And as mass vaccination against COVID-19 got underway early this year, experts cautioned against the temptation to attribute incident Guillain-Barré syndrome cases following vaccination to SARS-CoV-2 without careful statistical and epidemiological analysis.

Until now reports of Guillain-Barré syndrome have been scant: clinical trials of a viral vector vaccine developed by Johnson & Johnson saw one in the placebo arm and another in the intervention arm, while another case was reported following administration of a Pfizer mRNA SARS-Cov-2 vaccine.

Recent Case Reports

Two reports published this month in the Annals of Neurology — one from India and one from the United Kingdom — describe multiple cases of Guillain-Barré syndrome following a first dose of the ChAdOx1-S/nCoV-19, (Covishield, AstraZeneca) vector vaccine. None of the patients had evidence of current SARS-CoV-2 infection.

From India, Boby V. Maramattom, MD, of Aster Medcity in Kochi, India, and colleagues reported on seven severe cases of Guillain-Barré syndrome occurring between 10 and 14 days after a first dose of the AstraZeneca vaccine. All but one of the patients were women, all had bilateral facial paresis, all progressed to areflexic quadriplegia, and six required respiratory support. Patients’ ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement, which are rare in reports of Guillain-Barré syndrome from India, Maramattom and colleagues noted.

The authors argued that their findings “should prompt all physicians to be vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine. While the risk per patient (5.8 per million) may be relatively low, our observations suggest that this clinically distinct [Guillain-Barré syndrome] variant is more severe than usual and may require mechanical ventilation.”

The U.K. cases, reported by Christopher Martin Allen, MD, and colleagues at Nottingham (England) University Hospitals NHS Trust, describe bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine. This type of facial palsy, the authors wrote, was unusual Guillain-Barré syndrome variant that one rapid review found in 3 of 42 European patients diagnosed with Guillain-Barré syndrome following SARS-CoV-2 infection.

Allen and colleagues acknowledged that causality could not be assumed from the temporal relationship of immunization to onset of bifacial weakness in their report, but argued that their findings argued for “robust postvaccination surveillance” and that “the report of a similar syndrome in the setting of SARS-CoV-2 infection suggests an immunologic response to the spike protein.” If the link is casual, they wrote, “it could be due to a cross-reactive immune response to the SARS-CoV-2 spike protein and components of the peripheral immune system.”

“The Jury Is Still Out”

Asked for comment, neurologist Anthony Amato, MD, of Brigham and Women’s Hospital, Boston, said that he did not see what the two new studies add to what is already known. “Guillain-Barré syndrome has already been reported temporally following COVID-19 along with accompanying editorials that such temporal occurrences do not imply causation and there is a need for surveillance and epidemiological studies.”

Robert Lisak, MD, of Wayne State University, Detroit, and a longtime adviser to the GBS-CIDP Foundation International, commented that “the relationship between vaccines and association with Guillain-Barré syndrome continues to be controversial in part because Guillain-Barré syndrome, a rare disorder, has many reported associated illnesses including infections. Many vaccines have been implicated but with the probable exception of the ‘swine flu‘ vaccine in the 1970s, most have not stood up to scrutiny.”

With SARS-Cov-2 infection and vaccines, “the jury is still out,” Lisak said. “The report from the U.K. is intriguing since they report several cases of an uncommon variant, but the cases from India seem to be more of the usual forms of Guillain-Barré syndrome.”

Lisak noted that, even if an association turns out to be valid, “we are talking about a very low incidence of Guillain-Barré syndrome associated with COVID-19 vaccines,” one that would not justify avoiding them because of a possible association with Guillain-Barré syndrome.

The GBS-CIDP Foundation, which supports research into Guillain-Barré syndrome and related diseases, has likewise stressed the low risk presented by SARS-CoV-2 vaccines, noting on its website that “the risk of death or long-term complications from COVID in adults still far exceeds the risk of any possible risk of Guillain-Barré syndrome by several orders of magnitude.”

None of the study authors reported financial conflicts of interest related to their research. Amato is an adviser to the pharmaceutical firms Alexion and Argenx, while Lisak has received research support or honoraria from Alexion, Novartis, Hoffmann-La Roche, and others.

This article originally appeared on MDedge.com, part of the Medscape Professional Network.

Author: Jennie Smith
This post originally appeared on Medscape Medical News

Austin police identify teen murdered at weekend birthday party

AUSTIN (KXAN)– Austin Police say 19-year-old Javone Montre Hodges was killed during Sunday’s homicide on Robert Wooding Drive.

Investigators say a disturbance broke out between several individuals at a birthday party around 12:31 a.m. on Sunday, ending when a Black male suspect wearing a black shirt and blue jeans fired several shots.

Hodges was pronounced dead on the scene just before 1 a.m.

Javone Montre Hodges was expected to attend Mesabi Range College on a football scholarship (Courtesy Keesha Hodges)

According to his family, Hodges was a student-athlete who played football at Northeast Early College High School and was set to attend Mesabi Range College in Minnesota on a football scholarship this fall.

A fundraising campaign has been launched for Hodges’ funeral expenses as well as living expenses for the family during their grieving period.

“…Those who shared the field with him knew him as one of the toughest and hardest hitting players they ever faced. But off the field, he was one of the most kind-hearted people you hopefully had the pleasure of knowing,” reads the campaign.

Another male was also shot and is in serious condition at a local hospital, according to police.

Officers say the suspect fled the scene and are asking anyone with information or video of the incident to call APD Homicide at (512) 974-TIPS, email [email protected], utilize the Crime Stoppers tip line at (512) 472-8477 (TIPS), or the Crime Stoppers app.

You can also submit tips by downloading APD’s mobile app, Austin PD, free on iPhone and Android.

Information leading to an arrest may be eligible for a reward of up to $ 1,000.

You can remain anonymous.

Author: Tahera Rahman
This post originally appeared on KXAN Austin

Inheritance tax 'red flag' – How to identify legitimate and unethical heir hunters

Inheritance tax (IHT) is levied on the estate of someone who has died and is passing on their assets, so long as the total estate value is over £325,000. Where IHT is due, it is usually charged at 40 percent and in some cases, this charge can be paid by beneficiaries themselves.
IHT can be managed by the usage of Wills but in some instances, it can become unclear as to who is meant to inherit assets where a Will is not in place.

In light of these challenges, a “heir hunter” industry emerged and unfortunately, this has created an area where consumers and families could be targeted through dubious practices.

Philip Turvey, an executive director at Anglia Research, warned this could be a much more prevalent issue than many may expect.

He said: “The TV series Heir Hunters sensationalised the probate genealogy sector and, due to the lack of barriers to entry, this led to an exponential rise in the number of unethical, unqualified firms who have no qualms in engaging in underhand tactics at the expense of beneficiaries.

READ MORE: Attendance allowance: Pensioners may be eligible for council tax perks

“Our FOI report – which surveyed all local authorities in England and Wales – found that seven councils have exclusive written contracts with heir hunters: a practice which limits the amount of scrutiny given to each case.

“Some unethical heir hunters use these types of written contracts to only identify easy to find heirs to an estate, collect their fee and forgo the rest of the beneficiaries – potentially resulting years of legal battles for some to get the inheritance they are owed.

“Other unethical heir hunters also use pressure-selling tactics, such as emotional manipulation or pushing a beneficiary to sign a fee agreement by falsely telling them there is a deadline.”

Fortunately, Philip went on to break down how families can check if a claim from an heir hunter is legit and how unethical practices could be identified.

Virgin Money offers 2% interest rate account & ‘free’ gift worth £140 [DEAL]
Santander: You may get compensation as bank apologises for ‘issue’ [INSIGHT]
Inheritance tax UK: ‘The job is only half done’ through Wills

How beneficiaries can check if a claim from an heir hunter is legit

There are a number of basic actions families can take to ensure legitimacy, as Philip explained: “Probate genealogy firms usually get in touch via a letter, phone call or email, but just because they have your contact information, it doesn’t mean they are legit.

“Beneficiaries should do some initial research of their own into the probate genealogy firm before committing.

“For example, they could check to see if the firm is registered at Companies House which will show how long the company has been trading for. Independent online reviews, such as those provided by Google, are also worth reading to learn about the experience of others.

“Beneficiaries should also check the firm’s website and search for any valid and applicable accreditations.

“Beneficiaries must remember that the fee for a probate genealogist is always paid on the conclusion of the estate administration and usually by direct deduction from the amount you are entitled to.

“Any probate genealogist or heir hunter telling you differently, and requesting direct payment before this stage should not be trusted.

“Consumers need to remember this when dealing with a probate genealogist and check their rights before signing on the dotted line.”

Impartial guidance on inheritance, probate and Will rules can be sought from the likes of the Money Advice Service and Citizens Advice.

This post originally appeared on Daily Express :: Finance Feed

Man Utd get Jules Kounde transfer boost as Sevilla identify Tottenham replacement

That result, plus the humiliating Europa League capitulation against Dinamo Zagreb on Thursday, has piled the pressure on Spurs boss Jose Mourinho.

But from United’s point of view, the news that Sevilla are eyeing up Sanchez is a promising sign that they expect to do business over Kounde this summer.

The Red Devils have been linked with the France under-21 international for some time – although they are likely to face competition if they decide to swoop for the defender, with Arsenal also reportedly keen.

Kounde is believed to have been a target for Manchester City last summer, before Pep Guardiola’s side opted to sign Ruben Dias from Benfica – with the Portuguese star having since transformed their defence.